Literature DB >> 22736079

Rodent models and contemporary molecular techniques: notable feats yet incomplete explanations of Parkinson's disease pathogenesis.

Sharawan Yadav1, Anubhuti Dixit, Sonal Agrawal, Ashish Singh, Garima Srivastava, Anand Kumar Singh, Pramod Kumar Srivastava, Om Prakash, Mahendra Pratap Singh.   

Abstract

Rodent models and molecular tools, mainly omics and RNA interference, have been rigorously used to decode the intangible etiology and pathogenesis of Parkinson's disease (PD). Although convention of contemporary molecular techniques and multiple rodent models paved imperative leads in deciphering the role of putative causative factors and sequential events leading to PD, complete and clear-cut mechanisms of pathogenesis are still hard to pin down. The current article reviews the implications and pros and cons of rodent models and molecular tools in understanding the molecular and cellular bases of PD pathogenesis based on the existing literature. Probable rationales for short of comprehensive leads and future possibilities in spite of the extensive applications of molecular tools and rodent models have also been discussed.

Entities:  

Mesh:

Year:  2012        PMID: 22736079     DOI: 10.1007/s12035-012-8291-8

Source DB:  PubMed          Journal:  Mol Neurobiol        ISSN: 0893-7648            Impact factor:   5.590


  170 in total

1.  Paraquat neurotoxicity is mediated by the dopamine transporter and organic cation transporter-3.

Authors:  Phillip M Rappold; Mei Cui; Adrianne S Chesser; Jacqueline Tibbett; Jonathan C Grima; Lihua Duan; Namita Sen; Jonathan A Javitch; Kim Tieu
Journal:  Proc Natl Acad Sci U S A       Date:  2011-12-05       Impact factor: 11.205

2.  Minocycline inhibits microglial activation and protects nigral cells after 6-hydroxydopamine injection into mouse striatum.

Authors:  Y He; S Appel; W Le
Journal:  Brain Res       Date:  2001-08-03       Impact factor: 3.252

3.  CHOP/GADD153 is a mediator of apoptotic death in substantia nigra dopamine neurons in an in vivo neurotoxin model of parkinsonism.

Authors:  Robert M Silva; Vincent Ries; Tinmarla Frances Oo; Olga Yarygina; Vernice Jackson-Lewis; Elizabeth J Ryu; Phoebe D Lu; Stefan J Marciniak; David Ron; Serge Przedborski; Nikolai Kholodilov; Lloyd A Greene; Robert E Burke
Journal:  J Neurochem       Date:  2005-08-31       Impact factor: 5.372

4.  Redox modification of Akt mediated by the dopaminergic neurotoxin MPTP, in mouse midbrain, leads to down-regulation of pAkt.

Authors:  Lalitha Durgadoss; Prakash Nidadavolu; Rupanagudi Khader Valli; Uzma Saeed; Mamata Mishra; Pankaj Seth; Vijayalakshmi Ravindranath
Journal:  FASEB J       Date:  2011-12-23       Impact factor: 5.191

Review 5.  Environmental-induced oxidative stress in neurodegenerative disorders and aging.

Authors:  Lucia Migliore; Fabio Coppedè
Journal:  Mutat Res       Date:  2008-10-05       Impact factor: 2.433

6.  Striatal 19S Rpt6 deficit is related to alpha-synuclein accumulation in MPTP-treated mice.

Authors:  Bin Liu; Qiaoqiao Shi; Shiping Ma; Nan Feng; Jiang Li; Ling Wang; Xiaoliang Wang
Journal:  Biochem Biophys Res Commun       Date:  2008-09-07       Impact factor: 3.575

7.  Oxidative modifications and down-regulation of ubiquitin carboxyl-terminal hydrolase L1 associated with idiopathic Parkinson's and Alzheimer's diseases.

Authors:  Joungil Choi; Allan I Levey; Susan T Weintraub; Howard D Rees; Marla Gearing; Lih-Shen Chin; Lian Li
Journal:  J Biol Chem       Date:  2004-01-13       Impact factor: 5.157

8.  PINK1/Parkin-mediated mitophagy is dependent on VDAC1 and p62/SQSTM1.

Authors:  Sven Geisler; Kira M Holmström; Diana Skujat; Fabienne C Fiesel; Oliver C Rothfuss; Philipp J Kahle; Wolfdieter Springer
Journal:  Nat Cell Biol       Date:  2010-01-24       Impact factor: 28.824

9.  The organic cation transporter-3 is a pivotal modulator of neurodegeneration in the nigrostriatal dopaminergic pathway.

Authors:  Mei Cui; Radha Aras; Whitney V Christian; Phillip M Rappold; Mamata Hatwar; Joseph Panza; Vernice Jackson-Lewis; Jonathan A Javitch; Nazzareno Ballatori; Serge Przedborski; Kim Tieu
Journal:  Proc Natl Acad Sci U S A       Date:  2009-04-29       Impact factor: 11.205

10.  The emerging science of BMAA: do cyanobacteria contribute to neurodegenerative disease?

Authors:  Wendee Holtcamp
Journal:  Environ Health Perspect       Date:  2012-03       Impact factor: 9.031

View more
  18 in total

1.  Cypermethrin-induced nigrostriatal dopaminergic neurodegeneration alters the mitochondrial function: a proteomics study.

Authors:  Sonal Agrawal; Ashish Singh; Pratibha Tripathi; Manisha Mishra; Pradhyumna Kumar Singh; Mahendra Pratap Singh
Journal:  Mol Neurobiol       Date:  2014-04-24       Impact factor: 5.590

Review 2.  Is Gut Dysbiosis an Epicenter of Parkinson's Disease?

Authors:  Charul Rajput; Alika Sarkar; Nidhi Sachan; Neeraj Rawat; Mahendra Pratap Singh
Journal:  Neurochem Res       Date:  2021-01-05       Impact factor: 3.996

3.  Neuroprotective role of Withania somnifera root extract in maneb-paraquat induced mouse model of parkinsonism.

Authors:  Jay Prakash; Satyndra Kumar Yadav; Shikha Chouhan; Surya Pratap Singh
Journal:  Neurochem Res       Date:  2013-02-22       Impact factor: 3.996

4.  Cypermethrin alters the status of oxidative stress in the peripheral blood: relevance to Parkinsonism.

Authors:  Pratibha Tripathi; Ashish Singh; Sonal Agrawal; Om Prakash; Mahendra Pratap Singh
Journal:  J Physiol Biochem       Date:  2014-10-01       Impact factor: 4.158

5.  Withania somnifera alleviates parkinsonian phenotypes by inhibiting apoptotic pathways in dopaminergic neurons.

Authors:  Jay Prakash; Shikha Chouhan; Satyndra Kumar Yadav; Susan Westfall; Sachchida Nand Rai; Surya Pratap Singh
Journal:  Neurochem Res       Date:  2014-11-18       Impact factor: 3.996

Review 6.  Cytochrome P450 2D6 and Parkinson's Disease: Polymorphism, Metabolic Role, Risk and Protection.

Authors:  Mohd Sami Ur Rasheed; Abhishek Kumar Mishra; Mahendra Pratap Singh
Journal:  Neurochem Res       Date:  2017-09-04       Impact factor: 3.996

Review 7.  Proteomics in Human Parkinson's Disease: Present Scenario and Future Directions.

Authors:  Anubhuti Dixit; Rachna Mehta; Abhishek Kumar Singh
Journal:  Cell Mol Neurobiol       Date:  2019-06-12       Impact factor: 5.046

Review 8.  Does restraining nitric oxide biosynthesis rescue from toxins-induced parkinsonism and sporadic Parkinson's disease?

Authors:  Satya Prakash Gupta; Sharawan Yadav; Naveen Kumar Singhal; Manindra Nath Tiwari; Sarad Kumar Mishra; Mahendra Pratap Singh
Journal:  Mol Neurobiol       Date:  2013-07-31       Impact factor: 5.590

9.  Cyclosporine A and MnTMPyP Alleviate α-Synuclein Expression and Aggregation in Cypermethrin-Induced Parkinsonism.

Authors:  Sonal Agrawal; Anubhuti Dixit; Ashish Singh; Pratibha Tripathi; Dhirendra Singh; Devendra Kumar Patel; Mahendra Pratap Singh
Journal:  Mol Neurobiol       Date:  2014-11-05       Impact factor: 5.590

10.  Silymarin- and melatonin-mediated changes in the expression of selected genes in pesticides-induced Parkinsonism.

Authors:  Naveen Kumar Singhal; Amit Kumar Chauhan; Swatantra Kumar Jain; Rishi Shanker; Chetna Singh; Mahendra Pratap Singh
Journal:  Mol Cell Biochem       Date:  2013-08-22       Impact factor: 3.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.